Trials / Completed
CompletedNCT01855919
A Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain
Effect of Duloxetine 60 mg Versus Placebo in Patients With Chronic Low Back Pain in Japan
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 458 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 20 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to assess the efficacy and safety of duloxetine in participants with Chronic Low Back Pain (CLBP).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine | Administered orally |
| DRUG | Placebo | Administered orally |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2014-07-01
- Completion
- 2014-07-01
- First posted
- 2013-05-17
- Last updated
- 2015-07-23
- Results posted
- 2015-07-23
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01855919. Inclusion in this directory is not an endorsement.